Laura Rosu is a health economist with expertise in multi-country, within-trial economic evaluations. She holds an MSc in Health Economics from the University of York (2018), where her dissertation focused on the economic evaluation of health technologies for venous leg ulcer treatment in the UK. She also holds a PhD from LSTM (2023), where her research focused on the cost and cost-effectiveness of strategies and care models to reduce the burden of multi-drug resistant tuberculosis.
• Currently the health economic lead for Multilink
• Conducted patient and health system costing studies
• Designed questionnaires and provided training to in-country health economic focal persons for data collection
• Contributed to primary data collection and analysis for a USAID-funded grant, STREAM, focused on a shortened all-oral regimen for MDR-TB treatment
• Worked across diverse regions, including India, Ethiopia, Uganda, Moldova, Malawi, Tanzania and The Philippines, on a range of disease areas
• Demonstrates a strong track record of effective presentations to diverse audiences
• Member of the International Health Economics Association (IHEA)
• Active participant in the Career Development of Researchers (CADRE) working group at LSTM
Laura is currently working as a health economist for the STREAM trial. She is responsible for training and monitoring in-country data collection, as well as for conducting the economic evaluation.